Driehaus Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-526,732
| Closed | -$7.34M | – | 407 |
|
|
2024
Q3 | $7.34M | Sell |
526,732
-179,714
| -25% | -$2.5M | 0.06% | 253 |
|
|
2024
Q2 | $9.73M | Sell |
706,446
-12,565
| -2% | -$173K | 0.09% | 221 |
|
|
2024
Q1 | $11.9M | Buy |
719,011
+235,772
| +49% | +$3.89M | 0.12% | 223 |
|
|
2023
Q4 | $7.06M | Sell |
483,239
-5,079
| -1% | -$74.2K | 0.09% | 255 |
|
|
2023
Q3 | $5.99M | Buy |
488,318
+10,212
| +2% | +$125K | 0.08% | 272 |
|
|
2023
Q2 | $5.71M | Buy |
478,106
+6,222
| +1% | +$74.3K | 0.07% | 266 |
|
|
2023
Q1 | $6.31M | Sell |
471,884
-11,600
| -2% | -$155K | 0.09% | 276 |
|
|
2022
Q4 | $10.4M | Sell |
483,484
-6,488
| -1% | -$140K | 0.16% | 199 |
|
|
2022
Q3 | $9.81M | Sell |
489,972
-11,717
| -2% | -$235K | 0.15% | 194 |
|
|
2022
Q2 | $8.98M | Buy |
501,689
+98,231
| +24% | +$1.76M | 0.15% | 212 |
|
|
2022
Q1 | $4M | Sell |
403,458
-7,749
| -2% | -$76.9K | 0.05% | 309 |
|
|
2021
Q4 | $6.93M | Sell |
411,207
-20,239
| -5% | -$341K | 0.07% | 268 |
|
|
2021
Q3 | $10.2M | Sell |
431,446
-2,977
| -0.7% | -$70.6K | 0.12% | 230 |
|
|
2021
Q2 | $9.89M | Buy |
+434,423
| New | +$9.89M | 0.13% | 227 |
|